LPCN Lipocine Inc.
Price Chart
Executive Summary
Lipocine Inc. (LPCN) filed a prospectus supplement to its existing sales agreement with A.G.P./Alliance Global Partners, authorizing the potential sale of up to $50 million in common stock through an at-the-market (ATM) equity offering. This is a routine capital-raising mechanism and does not indicate an immediate sale of shares.
Actionable Insight
Monitor for future 424B filings or company announcements, which would signal an actual drawdown from this ATM facility and provide details on pricing and volume. The mere authorization of the facility is not a trading event.
Key Facts
- Lipocine Inc. (LPCN) filed a prospectus supplement on February 26, 2026.
- The filing relates to an existing sales agreement with A.G.P./Alliance Global Partners, originally entered into on April 26, 2024.
- The prospectus supplement authorizes the potential sale of up to $50,000,000 of common stock under the ATM program.
- The filing includes a legal opinion on the validity of the shares to be sold.
Financial Impact
Up to $50,000,000 in potential future dilution, subject to market conditions and company discretion.
Risk Factors
- Future sales under this program will be dilutive to existing shareholders.
- Sales are likely to occur when the stock price is rising, which could put downward pressure on the share price.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-008852 |
| Exhibit: ex5-1.htm | 0001493152-26-008852 |
| Document: 0001493152-26-008852-index-headers.html | 0001493152-26-008852 |
| Document: 0001493152-26-008852-index.html | 0001493152-26-008852 |
| Document: 0001493152-26-008852.txt | 0001493152-26-008852 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
1d ago
|
8-K
| $2.22 awaiting T+5 | awaiting T+5 | — | $2.24 (+1.13%) |
|
May 18, 2026
2d ago
|
8-K
| $2.29 awaiting T+5 | awaiting T+5 | — | $2.24 (−2.18%) |
|
May 7, 2026
13d ago
|
8-K
| $2.39 $2.32 | ▲ +2.93% | ▲ +4.43% | $2.24 (+6.28%) |
|
Apr 21, 2026
29d ago
|
8-K
| $2.42 $2.23 | ▲ +7.85% | ▲ +7.91% | $2.24 (+7.44%) |
|
Apr 2, 2026
6w ago
|
8-K
| $2.05 $2.20 | ▲ +7.32% | ▲ +3.70% | $2.24 (+9.27%) |
|
Apr 2, 2026
6w ago
|
8-K
| $2.05 $2.20 | ▼ −7.32% | ▼ −3.70% | $2.24 (−9.27%) |
|
Mar 4, 2026
11w ago
|
8-K
| $8.19 $8.05 | ▼ −1.71% | ▲ +0.53% | $2.24 (−72.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access